Results 51 to 60 of about 3,178,268 (185)

STRUCTURAL BIOINFORMATICS STUDY OF CYCLIN-DEPENDENT KINASES COMPLEXED WITH INHIBITORS

open access: yesEclética Química, 2018
The present work describes molecular models for the binary complexes CDK9, CDK5 and CDK1 complexed with Flavopiridol and Roscovitine. These structural models indicate that the inhibitors strongly bind to the ATP-binding pocket of CDKs and the structural ...
F. CANDURI   +3 more
doaj   +1 more source

Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas. [PDF]

open access: yesPLoS ONE, 2012
The cell cycle system is controlled in a timely manner by three groups of cyclins, cyclin dependent kinases and cyclin dependent kinase inhibitors. Abnormal alterations of cell cycle regulatory mechanisms are a common feature of many diseases including ...
Jin-Young Lee   +6 more
doaj   +1 more source

Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability

open access: yesFrontiers in Cell and Developmental Biology, 2021
DNA replication must be precisely controlled in order to maintain genome stability. Transition through cell cycle phases is regulated by a family of Cyclin-Dependent Kinases (CDKs) in association with respective cyclin regulatory subunits. In normal cell
Rafaela Fagundes, Leonardo K. Teixeira
doaj   +1 more source

Correlation between Cyclin Dependent Kinases and Artemisinin-Induced Dormancy in Plasmodium falciparum In Vitro. [PDF]

open access: yesPLoS ONE, 2016
Artemisinin-induced dormancy provides a plausible explanation for recrudescence following artemisinin monotherapy. This phenomenon shares similarities with cell cycle arrest where cyclin dependent kinases (CDKs) and cyclins play an important role ...
Karen-Ann Gray   +8 more
doaj   +1 more source

Induction of apoptosis in cancer cells by tumor necrosis factor and butyrolactone, an inhibitor of cyclin-dependent kinases

open access: yesBrazilian Journal of Medical and Biological Research, 1999
Induction of apoptosis by tumor necrosis factor (TNF) is modulated by changes in the expression and activity of several cell cycle regulatory proteins.
J.E. Belizário, S. Sherwood, W. Beçak
doaj   +1 more source

Cyclin-Dependent Kinases: CAK-handed kinase activation

open access: yes, 1995
A protein kinase that activates cyclin-dependent kinases has been identified as a related catalytic subunit in association with a novel cyclin regulatory subunit – it is itself a cyclin-dependent ...
Clarke, PR, Clarke, Paul R.
core   +1 more source

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

open access: yesCells, 2019
Breast Cancer (BC) is the second most common type of cancer worldwide and displays the highest cancer-related mortality among women worldwide. Targeted therapies have revolutionized the way BC has been treated in recent decades, improving the life ...
Navid Sobhani   +8 more
doaj   +1 more source

SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: a license to destroy

open access: yesCell Division, 2007
Cyclin D1 is an allosteric regulator for cyclin-dependent kinases 4 and 6 (CDK4/6). The cyclin D/CDK4 kinase promotes G1/S transition through the posttranslational modification and the subsequent inactivation of the retinoblastoma (Rb) protein and ...
Lin Douglas I   +2 more
doaj   +1 more source

The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity

open access: yes, 2002
The pathological features of Alzheimer's disease include deposition of amyloid-β (Aβ) containing plaques and increases in the expression of cyclin-dependent kinase (CDK) enzymes.
Milton, N.G.N.
core   +1 more source

Inhibition of cyclin-dependent kinases by purine analogues

open access: yes, 1994
While testing purines related to the non-specific protein kinase inhibitors N6-dimethylaminopurine and N6-(delta2-isopentenyl)adenine as potential inhibitors of the p34cdc2/cyclin B kinase, we discovered a compound with high specificity, 2-(2 ...
Strnad, Miroslav   +31 more
core   +1 more source

Home - About - Disclaimer - Privacy